David Hibbert Watson, President and Chief Executive Officer of Argan Inc. (NASDAQ: AGX), sold 19,310 shares of common stock in an open-market transaction on April 17, 2026. The disposal generated proceeds of $11,626,744, reflecting an average sale price of $602.11 per share.
The trade occurred as Argan shares were trading close to their 52-week high of $620, following a 313% total return over the prior 12 months. Market analysis noted in the transaction report indicates the stock appears overvalued relative to its Fair Value estimate, according to InvestingPro.
This sale came on the heels of several internal equity distributions to Mr. Watson arising from the vesting of restricted stock units (RSUs) across April 16 and April 17, 2026. Those issuances were recorded at a cost basis of $0 per share, as the awards vested rather than being purchased in the market.
On April 16, 2026, Mr. Watson received 1,869 shares from Time-Based Restricted Stock Units (TRSUs) originally awarded on April 16, 2024, where 3,333 shares became issuable. He also received 736 shares from TRSUs granted on April 16, 2025, from a pool in which 1,333 shares became issuable. The company states both series of TRSUs vested under a three-year schedule and were adjusted for dividends.
On April 17, 2026, additional vesting occurred. Mr. Watson acquired 2,302 shares from TRSUs awarded April 17, 2023, where 4,000 shares became issuable. In the same reporting period he received 11,513 shares from Earnings Per Share Performance-Based Restricted Stock Units (ERSUs) and 5,756 shares from Performance-Based Restricted Stock Units (PRSUs), both awarded on April 17, 2023. For the ERSUs, 20,000 shares became issuable after a three-year performance period, with a target issuance of 10,000 shares. For the PRSUs, 10,000 shares became issuable after a three-year performance period, with a target of 5,000 shares. The company’s filings note that all of these units were adjusted for dividends.
Following the reported open-market sale and the aggregate vesting activity, Mr. Watson is recorded as directly holding 49,998 shares of Argan common stock.
InvestingPro subscribers have access to additional coverage on AGX, including more than 20 extra tips, commentary on the company’s strong financial health score and observations on dividend growth. The platform’s Pro Research Report provides expanded analysis of Argan alongside research on over 1,400 other U.S. equities.
Separately, Argan reported results for fiscal 2026 fourth quarter showing earnings per share of $3.47, beating analysts’ expectation of $2.13. Revenue for the quarter came in at $262.1 million, slightly below the consensus estimate of $271.02 million.
The company’s board has increased the size of its share repurchase program from $150 million to $200 million and extended the program through January 31, 2030. In addition, the Board declared a quarterly cash dividend of $0.50 per common share, payable on April 30, 2026, to shareholders of record as of April 22, 2026. These measures were cited as steps the company is taking to deliver shareholder value.
Contextual note - The reported insider sale and the clustered vesting of multiple RSU awards are recorded in the company’s filings and transaction reports. The transaction values, vesting schedules and post-transaction shareholdings are reported precisely as disclosed in the filings and research notes associated with AGX.